Three Pathways, Not One

Each pathway operates through a distinct biological mechanism. Each requires a distinct intervention. Most corporate nutrition programmes address one, at most, and do it imprecisely.

The Sugar-and-Willpower Myth Needs Correcting

This is the area requiring the most honesty, because it is the foundation of a great deal of popular executive nutrition advice. The widely cited theory, sometimes called ego depletion, proposed that the prefrontal cortex relies heavily on glucose for effortful, controlled executive tasks, and that consuming sugar could directly replenish depleted willpower. This was an influential model. It shaped a generation of advice telling executives to keep glucose tablets or sugary snacks at their desk for decision-heavy afternoons.

The problem is that subsequent, more rigorous research has not supported this specific mechanism well. A widely cited critical review concluded that the beneficial effects of glucose ingestion on self-control were difficult to replicate and were probably more psychological than biological. A controlled study using the antisaccade task, a well-validated measure of self-control requiring inhibition of an automatic eye movement, found that glucose did not enhance performance following a prior bout of effortful cognitive work. Motivation, not glucose, predicted subsequent performance.

The mechanistic picture that has replaced the simple depletion model involves the build-up of the excitatory neurotransmitter glutamate in specific prefrontal regions during prolonged effortful cognition, alongside the possibility that reduced prefrontal activity under sustained load reflects a functional adaptation rather than the brain literally running out of fuel.

What the Large-Scale Evidence Actually Shows

Two large-scale analyses, a 2025 Framingham cohort analysis and a separate 2024 meta-analysis spanning nine cohorts, found a 25 to 35 percent excess risk of all-cause dementia in the highest ultra-processed food consumption quintile compared with the lowest. A widely cited 2024 study published in Neurology found that people consuming high amounts of ultra-processed food were more likely to experience cognitive decline or stroke, while those eating predominantly unprocessed diets showed reduced risk.

The honest caveat: the substantial majority of this evidence base remains observational rather than causally established through randomised controlled trials. A systematic review through October 2024 identified only five studies meeting inclusion criteria after screening several hundred candidate articles, all published within a narrow 2022 to 2024 window. This remains a young and still-consolidating area of research. The mechanistic plausibility is strong. But the field has not yet produced the large randomised controlled trial evidence that would allow confident causal claims about effect size for a healthy working-age population specifically.

I will not tell you ultra-processed food definitively causes cognitive decline. I will tell you the association is consistent, the biological pathways are coherent, and the direction of the evidence gives you a clear enough signal to act on while the field matures.

Similarly with omega-3 fatty acids. DHA is the dominant long-chain omega-3 in the brain, incorporated into neuronal membranes where it supports neurogenesis, neuroplasticity, and neurotransmission speed. The biological rationale is sound. But a meta-analysis combining results across multiple randomised controlled trials in patients with cognitive impairment did not find a significant treatment effect for memory outcomes. A more recent and larger 2025 dose-response meta-analysis spanning 58 studies found a significant improvement in attention and perceptual speed at higher supplementation doses, but the strength of evidence was graded as low under the GRADE framework.

The India-Specific Picture Is Unusually Clear, and Unusually Concerning

Unlike several other performance topics, India-specific corporate nutrition research is available, recent, and directly relevant. Research examining diets, lifestyles, and metabolic risk factors among corporate IT employees in South India found that perceived stress scores were notably higher among senior, managerial-level employees compared with junior staff, and that this elevated stress was positively correlated with oxidative stress biomarkers (malondialdehyde, interleukin-6, interleukin-4, homocysteine) with documented relevance to both cardiovascular and cognitive health.

A cross-sectional study of urban working professionals in Mumbai aged 30 to 40 found a striking result: 89.3 percent of participants had less than half the estimated average requirement for vitamin B12. This is not a population lacking access or resources. These are well-educated, well-compensated professionals, the exact demographic that fills leadership roles across Indian corporates.

B12 is not a minor nutrient for cognitive function. Its deficiency is linked to neurological impairment, cognitive decline, and fatigue. Iron tells a parallel story, specifically for women. Iron deficiency anaemia prevalence among Indian adolescent girls has been measured at approximately 50 percent. Research distinguishing iron deficiency from iron deficiency anaemia found that anaemia specifically was associated with reduced attention in healthy young women, after adjusting for BMI, physical activity, and inflammatory markers. A separate study found statistically significant reductions in attention span, calculation ability, and orientation among women with iron deficiency anaemia compared with iron-replete women.

A meaningful proportion of women within any Indian corporate workforce may be carrying a directly performance-relevant nutritional deficit, measurable and addressable, that is being entirely ignored by generic wellness programming.

What Actually Works

The evidence separates clearly into two columns: what the research genuinely supports and what remains popular despite weak or contradicted evidence.

Beyond the highest-priority interventions, three additional levers have strong supplementary evidence behind them:

In the Indian corporate context specifically, the data points to workforce-level nutritional gaps in B12, iron, and metabolic risk markers that are simultaneously well-documented and widely ignored. A serious corporate performance programme does not stop at telling people to eat healthier. It diagnoses the specific nutritional vulnerabilities present in your workforce, addresses the structural food environment that shapes daily intake, and builds interventions around the mechanisms that actually connect what people eat to how well they think, decide, and lead.